Combination Therapy with Atezolizumab plus Bevacizumab for TACE Unsuitable Patients in Intermediate Stage Up-to-Seven Out Hepatocellular Carcinoma - a phase II study- (REPLACEMENT)

Status: Active, no longer recruiting

Phase of Trial: Phase II

Latest Information Update: 14 Oct 2024

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

06 Jun 2023 Results of a primary analysis presented at the 59th Annual Meeting of the American Society of Clinical Oncology
25 Jul 2021 New trial record
08 Jun 2021 Results presented at the 57th Annual Meeting of the American Society of Clinical Oncology

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com